Multikinase inhibitor sorafenib prevents pressure overload-induced left ventricular hypertrophy in rats by blocking the c-Raf/ERK1/2 signaling pathway

BACKGROUND: Left ventricular hypertrophy (LVH) is a potent risk factor for sudden death and congestive heart failure. METHODS: We tested the effect of sorafenib, a multikinase inhibitor (10 mg/kg, given orally, starting 2 days prior to banding, till sacrifice on day 14), on the development of LVH fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Daryadel, Arezoo, Bogdanova, Anna, Gassmann, Max, Mueller, Xavier, Zünd, Gregor, Seifert, Burkhardt, Lehalle, Christine, Frossard, Nelly, Tavakoli, Reza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4042218/
https://www.ncbi.nlm.nih.gov/pubmed/24885948
http://dx.doi.org/10.1186/1749-8090-9-81

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4042218/
https://www.ncbi.nlm.nih.gov/pubmed/24885948
http://dx.doi.org/10.1186/1749-8090-9-81

Ejemplares similares